(Bloomberg) -- Pfizer Inc. plans to sell about £2 billion ($2.5 billion) of shares in Haleon Plc, the first step by the UK consumer health company’s biggest shareholder to reduce its 32% stake. Most Read from BloombergApple Is in Talks to Let Google Gemini Power iPhone AI FeaturesPutin Warns Russia Won’t Stop After Predictable Election WinSaudi Wealth Fund Is in Talks to Acquire National AirlineTop Solar Firm Longi Plans Thousands of Job Cuts on GlutChina’s Growth Bump May Dent Urgency for More
These FTSE 100 shares could be too cheap to miss, according to our writer Royston Wild. Here's why they're on his ISA shopping list. The post 2 last-minute FTSE 100 shares I’m considering buying before the ISA deadline appeared first on The Motley Fool UK.
PHILADELPHIA, March 16, 2024--RUBY phase III data show potential for Jemperli (dostarlimab-gxly) combinations in more patients with primary advanced or recurrent endometrial cancer